| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Transgenic Mice1
Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912 [G-H. L., N. F.], and Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892 [G. M.]
We studied the development of liver tumors in male transforming growth factor 
(TGF-) transgenic mice of the CD1 strain and examined the expression of the transgene by immunohistochemistry and in situ hybridization. Livers of 4–5-week-old transgenic mice contained areas of centribobular hypertrophy with low glucose-6-phosphatase activity. These areas progressively expanded, and hypertrophy and dysplasia became generalized in livers of mice at 10–12 months of age. The expression of the transgene, determined by either immunohistochemistry or in situ hybridization, was uneven in animals that were 10 weeks old or older. The positive hepatocytes formed patches with a predominant centrilobular distribution. We studied a total of 23 liver tumors (7 hepatocellular carcinomas and 16 adenomas) obtained from 11 mice at 13–15 months of age and from one 7-month-old animal which received zinc sulfate to induce the transgene. The carcinomas were well differentiated tumors, without glucose-6-phosphatase or 
-glutamyltranspeptidase activity, that developed from the dysplastic parenchyma and occasionally within an adenoma. In all carcinomas and in 56% of the adenomas there was overexpression of the transgene in relationship to the surrounding tissue. The majority of the tumors that overexpressed TGF- were -fetoprotein positive, while -fetoprotein staining was not detected in tumors (all adenomas) that did not show excessive transgene expression. We conclude that TGF- functions as a promoter of liver carcinogenesis through its effect as an autocrine inducer of hepatocyte proliferation. Further, the data indicate that TGF- overexpression may favor tumor progression.
1 Supported by Grant CA23226 from the National Cancer Institute.
2 Present address: McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706.
3 To whom requests for reprints should be addressed, at the Department of Pathology and Laboratory Medicine, Box G, Providence, RI 02912.
Received 4/ 1/92. Accepted 7/21/92.
This article has been cited by other articles:
|
|
 |
|
  R. Read, G. Hansen, J. Kramer, R. Finch, L. Li, and P. Vogel Ectonucleoside Triphosphate Diphosphohydrolase Type 5 (Entpd5)-Deficient Mice Develop Progressive Hepatopathy, Hepatocellular Tumors, and Spermatogenic Arrest Vet. Pathol., May 1, 2009; 46(3): 491 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Calvisi, F. Pinna, S. Ladu, R. Pellegrino, M. R. Muroni, M. M. Simile, M. Frau, M. L. Tomasi, M. R. De Miglio, M. A. Seddaiu, et al. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease Carcinogenesis, August 1, 2008; 29(8): 1639 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Sato, J Kato, R Takimoto, K Takada, Y Kawano, K Miyanishi, M Kobune, Y Sato, T Takayama, T Matunaga, et al. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor {alpha} expression via activation of nuclear factor-{kappa}B Gut, December 1, 2006; 55(12): 1801 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Huang, C. Yu, C. Jin, M. Kobayashi, C. A. Bowles, F. Wang, and W. L. McKeehan Ectopic Activity of Fibroblast Growth Factor Receptor 1 in Hepatocytes Accelerates Hepatocarcinogenesis by Driving Proliferation and Vascular Endothelial Growth Factor-Induced Angiogenesis Cancer Res., February 1, 2006; 66(3): 1481 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dombrowski, C. Mathieu, and M. Evert Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats Cancer Res., February 1, 2006; 66(3): 1833 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, W. Dong, X. Zhou, and S. Li The Significance of Serum Soluble Intercellular Adhesion Molecule 1 and Transforming Growth Factor {alpha} in Patients With Nasopharyngeal Carcinoma Arch Otolaryngol Head Neck Surg, October 1, 2004; 130(10): 1205 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kagawa, T. Sano, N. Ishibashi, M. Hashimoto, M. Okuno, H. Moriwaki, R. Suzuki, H. Kohno, and T. Tanaka An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-{alpha} expression and cell proliferation Carcinogenesis, June 1, 2004; 25(6): 979 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Grey, C. Longo, T. Shukri, V. I. Patel, E. Csizmadia, S. Daniel, M. B. Arvelo, V. Tchipashvili, and C. Ferran Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves {beta} Cell Mass and Function J. Immunol., June 15, 2003; 170(12): 6250 - 6256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nicholes, S. Guillet, E. Tomlinson, K. Hillan, B. Wright, G. D. Frantz, T. A. Pham, L. Dillard-Telm, S. P. Tsai, J.-P. Stephan, et al. A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice Am. J. Pathol., June 1, 2002; 160(6): 2295 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Gorla, H. Malhi, and S. Gupta Polyploidy associated with oxidative injury attenuates proliferative potential of cells J. Cell Sci., March 10, 2002; 114(16): 2943 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bugni, T. M. Poole, and N. R. Drinkwater The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility Carcinogenesis, November 1, 2001; 22(11): 1853 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hufnagl, W. Parzefall, B. Marian, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp Role of transforming growth factor {alpha} and prostaglandins in preferential growth of preneoplastic rat hepatocytes Carcinogenesis, August 1, 2001; 22(8): 1247 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sakairi, K. Kobayashi, K. Goto, M. Okada, M. Kusakabe, T. Tsuchiya, J. Sugimoto, F. Sano, and M. Mutai Greater Expression of Transforming Growth Factor {alpha} and Proliferating Cell Nuclear Antigen Staining in Mouse Hepatoblastomas Than Hepatocellular Carcinomas Induced by a Diethylnitrosamine-Sodium Phenobarbital Regimen Toxicol Pathol, June 1, 2001; 29(4): 479 - 482. [Abstract] [PDF]
|
|
|
|
|
|
M. E. Vail, R. H. Pierce, and N. Fausto Bcl-2 Delays and Alters Hepatic Carcinogenesis Induced by Transforming Growth Factor {{alpha}} Cancer Res., January 1, 2001; 61(2): 594 - 601. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kobayashi, M. Kusakabe, M. Okada, T. Sakairi, K. Goto, T. Tsuchiya, J. Sugimoto, F. Sano, and M. Mutai Immunohistochemical Localization of Transforming Growth Factor Alpha in Chemically Induced Rat Hepatocellular Carcinomas with Reference to Differentiation and Proliferation Toxicol Pathol, September 1, 2000; 28(5): 664 - 667. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Jo, D. B. Stolz, J. E. Esplen, K. Dorko, G. K. Michalopoulos, and S. C. Strom Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells J. Biol. Chem., March 17, 2000; 275(12): 8806 - 8811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-H. Lee Review Article: Paradoxical Effects of Phenobarbital on Mouse Hepatocarcinogenesis Toxicol Pathol, March 1, 2000; 28(2): 215 - 225. [Abstract] [PDF]
|
|
|
|
|
|
B. F. Trump Mechanisms of Toxicity and Carcinogenesis Toxicol Pathol, November 1, 1995; 23(6): 775 - 827. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
